2012 Annual Meeting | Update in Neuroimaging: Essentials and BeyondPart I

Date Friday 04/27/12

Time 09:00 AM - 05:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Full-Day Course

Director(s) Joseph C. Masdeu, MD, PhD, FAAN

Topic(s)

Learning Objectives Participants should be able to describe an organized approach to reading neuroimaging studies, as well as the indications and most frequent imaging patterns in patients with brain or spine tumors, epilepsy, multiple sclerosis, dementia, and headache. They should also be able to list some of the applications of interventional neuroimaging to diseases of the brain.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Recommended Audience Trainee, General Neurologist, Specialist Neurologist

Teaching Styles Didactic, Interactive, Audience Participation

Program Evaluations

Event Timeline
09:00 AM - 09:05 AM		Introduction Joseph C. Masdeu, MD, PhD, FAAN
09:05 AM - 09:50 AM		Checklist for Neuroimaging: An Organized Approach James G. Smirniotopoulos, MD
09:50 AM - 10:35 AM		Advanced Neuroimaging of Brain Tumors Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN
10:35 AM - 10:50 AM		Break
10:50 AM - 11:35 AM		Multiple Sclerosis: New Insights from Neuroimaging Nancy L. Sicotte, MD, FAAN
11:35 AM - 12:20 PM		Epilepsy Gregory D. Cascino, MD, FAAN
12:20 PM - 02:00 PM		Lunch
02:00 PM - 02:40 PM		Interventional Neuroimaging Rishi Gupta, MD
02:40 PM - 03:25 PM		MRI and CT of Intracranial Hemorrhage Eric C. Lindzen, MD, PhD
03:25 PM - 03:40 PM		Break
03:40 PM - 04:20 PM		Dementia Joseph C. Masdeu, MD, PhD, FAAN
04:20 PM - 05:00 PM		Spinal Neoplasms James G. Smirniotopoulos, MD

Faculty Disclosures
Joseph C. Masdeu, MD, PhD, FAAN	Dr. Masdeu has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Masdeu has received research support from NIH. The institution of Dr. Masdeu has received research support from Moody Foundation. The institution of Dr. Masdeu has received research support from Biogen. The institution of Dr. Masdeu has received research support from Eli Lilly. The institution of Dr. Masdeu has received research support from Eisai. The institution of Dr. Masdeu has received research support from Novartis. Dr. Masdeu has received publishing royalties from a publication relating to health care. Dr. Masdeu has received personal compensation in the range of $100,000-$499,999 for serving as a Director, Nantz Nal Alzheimer Center with HOUSTON METHODIST NEUROLOGICAL INSTITUTE.
Nancy L. Sicotte, MD, FAAN	The institution of Dr. Sicotte has received research support from PCORI. The institution of Dr. Sicotte has received research support from NIH. The institution of Dr. Sicotte has received research support from NMSS. Dr. Sicotte has a non-compensated relationship as a National Medical Advisory Committee Chair with National MS Society that is relevant to AAN interests or activities.
Eric C. Lindzen, MD, PhD	No disclosure on file
Gregory D. Cascino, MD, FAAN	Dr. Cascino has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for International League Against Epilepsy . Dr. Cascino has received intellectual property interests from a discovery or technology relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care. Dr. Cascino has received publishing royalties from a publication relating to health care.
Laszlo Mechtler, MD, FEAN, FASN, FAHS, FAAN	Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel Pharma. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Mechtler has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Abbvie. Dr. Mechtler has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Genomate Health. The institution of Dr. Mechtler has received research support from The Harry Dent Family Foundation, Inc. The institution of Dr. Mechtler has received research support from Alpheus medical. The institution of Dr. Mechtler has received research support from Shiratronics. The institution of Dr. Mechtler has received research support from Abbvie Inc. The institution of Dr. Mechtler has received research support from Amgen. The institution of Dr. Mechtler has received research support from Eli Lilly Company. The institution of Dr. Mechtler has received research support from H. Lundbeck HS. The institution of Dr. Mechtler has received research support from Pfizer. Dr. Mechtler has received personal compensation in the range of $100,000-$499,999 for serving as a Ownership interest with Neurology Practce Consortium GPO. Dr. Mechtler has a non-compensated relationship as a Board member with International Headache Society that is relevant to AAN interests or activities.
Rishi Gupta, MD	No disclosure on file
James G. Smirniotopoulos, MD	No disclosure on file

��ɫ��

��ɫ��